1. Home
  2. BCYC vs TRS Comparison

BCYC vs TRS Comparison

Compare BCYC & TRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCYC
  • TRS
  • Stock Information
  • Founded
  • BCYC 2009
  • TRS 1986
  • Country
  • BCYC United Kingdom
  • TRS United States
  • Employees
  • BCYC N/A
  • TRS N/A
  • Industry
  • BCYC Biotechnology: Pharmaceutical Preparations
  • TRS Industrial Specialties
  • Sector
  • BCYC Health Care
  • TRS Industrials
  • Exchange
  • BCYC Nasdaq
  • TRS Nasdaq
  • Market Cap
  • BCYC 896.2M
  • TRS 969.0M
  • IPO Year
  • BCYC 2019
  • TRS 2007
  • Fundamental
  • Price
  • BCYC $11.66
  • TRS $22.59
  • Analyst Decision
  • BCYC Buy
  • TRS Strong Buy
  • Analyst Count
  • BCYC 9
  • TRS 1
  • Target Price
  • BCYC $33.25
  • TRS $40.00
  • AVG Volume (30 Days)
  • BCYC 295.8K
  • TRS 372.5K
  • Earning Date
  • BCYC 03-04-2025
  • TRS 02-27-2025
  • Dividend Yield
  • BCYC N/A
  • TRS 0.71%
  • EPS Growth
  • BCYC N/A
  • TRS N/A
  • EPS
  • BCYC N/A
  • TRS 0.64
  • Revenue
  • BCYC $36,898,000.00
  • TRS $906,520,000.00
  • Revenue This Year
  • BCYC $41.07
  • TRS $4.36
  • Revenue Next Year
  • BCYC N/A
  • TRS $5.70
  • P/E Ratio
  • BCYC N/A
  • TRS $35.28
  • Revenue Growth
  • BCYC 48.60
  • TRS 2.17
  • 52 Week Low
  • BCYC $11.14
  • TRS $22.24
  • 52 Week High
  • BCYC $28.67
  • TRS $28.51
  • Technical
  • Relative Strength Index (RSI)
  • BCYC 34.58
  • TRS 31.67
  • Support Level
  • BCYC $11.14
  • TRS $23.69
  • Resistance Level
  • BCYC $13.11
  • TRS $24.32
  • Average True Range (ATR)
  • BCYC 0.69
  • TRS 0.58
  • MACD
  • BCYC 0.08
  • TRS -0.12
  • Stochastic Oscillator
  • BCYC 22.32
  • TRS 4.83

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC.

About TRS TriMas Corporation

TriMas Corp is a United States-based company that designs, manufactures, and distributes engineered and applied products. The company operates through three segments namely: The packaging segment manufactures and distributes closure and dispensing systems. The aerospace segment supplies blind bolts, fasteners, rivets, and other products for the aerospace industry. The specialty product segment manufactures and distributes steel cylinders, wellhead engines, compression systems, industrial sealing, and fasteners.

Share on Social Networks: